Navigation Links
Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
Date:9/3/2009

asured were: inattentiveness/being easily distracted, running around or climbing excessively, arguing with adults, losing temper, and interrupting or intruding on others. Significant improvements were seen on both scales: based on the CPRS-R, parents reported significant improvement across a full day (as measured at 6 pm, 8 pm, and 6 am the next morning); based on the CTRS-R, which was used only in the first pivotal trial, teachers reported significant improvement throughout the school day (as measured at 10 am and 2 pm).

Investigators also measured the efficacy of INTUNIV with the Clinical Global Impressions-Improvement (CGI-I) scale, a standard assessment used to rate the improvement of a patient's illness over the course of the study. The first pivotal trial found the percentage of subjects taking INTUNIV who were rated "much improved" or "very much improved" at end point ranged from approximately 50 to 56 percent across all doses versus approximately 26 percent for placebo (P<.05). Subjects taking INTUNIV in the second pivotal trial who rated "much improved" or "very much improved" at end point ranged from 54 to 56 percent across 1-mg (P=.0070), 3-mg (P=.0060), and 4-mg (P=.0040) doses versus 30 percent for placebo; the placebo-INTUNIV difference for the 2-mg dose was not significant (P=.1404).

Safety was also evaluated during these pivotal trials and safety data showed that adverse events reported by participants using INTUNIV were generally mild to moderate in severity, with the most common side effects being sedative in nature. Sedation-related, treatment-emergent adverse events were among the most common and were usually transient and mild to moderate in severity. Treatment-related adverse events greater than 10 percent included somnolence (32 percent), headache (26 percent), fatigue (18 percent), upper abdominal pain (14 percent), and sedation (13 percent). Small to modest changes in blood pressure, pu
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Inc. (NASDAQ: UPI ), a medical device ... products to treat voiding dysfunctions, today reported financial ... 30, 2014.  Global revenue for the ... to $4.1 million, as compared to $3.4 million ... Total revenue for the fiscal first quarter of ...
(Date:7/24/2014)... -- Mettler-Toledo International Inc. (NYSE: MTD ) today ... the highlights: , Sales in local currency ... prior year. Reported sales increased 5% which included a ... diluted share as reported (EPS) were $2.49, compared with ... was $2.57, an increase of 9% over the prior-year ...
(Date:7/24/2014)... , July 24, 2014 Amgen (NASDAQ: ... second quarter financial results on Tuesday, July 29, 2014, after ... be followed by a conference call with the investment community ... will be Robert A. Bradway , chairman and chief ... Live audio of the conference call will be ...
Breaking Medicine Technology:Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14Amgen Announces Webcast of 2014 Second Quarter Financial Results 2
... 2011 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT ) ... the second quarter 2011 prior to the open of the ... H. Johnson, Chief Executive Officer and President, and David Gionco, ... investment community conference call beginning at 9:00 a.m. Eastern Time ...
... Accuray Incorporated (Nasdaq: ARAY ), ... symposium examining best practices for quality assurance in ... of Physicists in Medicine (AAPM)/Canadian Organization of Medical ... Programs for Today,s Radiation Oncology Platforms "—will discuss ...
Cached Medicine Technology:Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011 2Accuray Hosts Symposium on Quality Assurance in Radiation Oncology at Joint AAPM/COMP Meeting 2
(Date:7/25/2014)... July 25, 2014 ZeptoMetrix™ Corporation ... reliable and trusted products and services for infectious ... release of NATtrol™ RP Multimarker Controls - ... in vitro diagnostic, CE marked, unassayed external run ... assays the NATtrol™ RP Multimarker Controls - MDZ001 ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Healthpointe ... Mirada clinic is offering Occupational Medicine services ... is happily accepting referrals and workers’ compensation cases. ... La Mirada clinic include wound care treatment management, ... ergonomic assessments, pre-employment screening & physicals, and illness ...
(Date:7/25/2014)... Vegas, NV (PRWEB) July 25, 2014 ... the one day Online Workshop ‘Consciousness is Power’ on ... globe are invited to attend this life transforming event ... consciousness to a higher level. Few days are left ... this workshop, Mahendra Trivedi and Trivedi Masters™ Dahryn Trivedi ...
(Date:7/25/2014)... FL (PRWEB) July 25, 2014 iTanSmart ... iPods, and iPads. The app provides a tailored approach ... and potentially dangerous sunburns and skin damage. In his ... sights, sounds, and capabilities of iTanSmart. , Eaton ... the app as a ‘better organized’ and ‘great alternative’ ...
(Date:7/25/2014)... Tampa, FL (PRWEB) July 25, 2014 ... launches their innovative toothbrushes with antibacterial silver that naturally kill ... land on the brush. , A toothbrush is the ... diseases, dental health and hygiene, however, it is subject to ... the air. , There are more bacteria in the mouth ...
Breaking Medicine News(10 mins):Health News:ZeptoMetrix™ Corporation (ZMC) Releases FDA Class 1 Exempt, IVD and CE Labeled NATtrol™ RP Multimarker Controls 2Health News:Healthpointe Offering Occupational Medicine Services in La Mirada 2Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 2Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 3Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 2Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 3Health News:Silver®Care’s New Silver Antibacterial Toothbrushes Naturally Kill Oral Germs 2Health News:Silver®Care’s New Silver Antibacterial Toothbrushes Naturally Kill Oral Germs 3
... a research news published says, in people with mild ... and about halve the dose of preventer inhaler//. ... breathing techniques on symptoms, lung function, use of medication ... asthma. ,One technique focused on shallow, nasal ...
... of Australia(COSA), which conducted a review of country hospitals ... little or no training, to administer chemotherapy to ... posed a risk to these patients. ... that the patient (might) be under-dosed, so they have ...
... researchers from The Institute for Genomic Research, (TIGR), in Maryland, ... in the GI system, stated that we may not be ... by studying the bacteria that are always present in our ... and as to how certain drugs could work on certain ...
... survey conducted by UNAIDS has put India on par with ... have the highest estimated number of HIV infected people//. ... the UNAIDS 2006 Report on the Global AIDS Epidemic is ... adults above 49 years of age whereupon the Indian HIV ...
... the second highest success rate in heart surgeries, ensuring that ... success stories, the group's chairman Prathap C Reddy said here ... celebration, he said while the hospital that had the highest ... more cost effective as it charged less than 4,000 dollars. ...
... Making an about-turn, Delhi's Apollo Hospital today disclosed that traces ... sample of Rahul Mahajan//, a day after its doctors had ... tested negative for all known drugs. ,'Traces of ... Since its cocktail of drugs, we cannot conclusively say which ...
Cached Medicine News:Health News:Humans, A Symbiotic Organisms Dependent On Other Life Forms For Existence 2
Innotrac Aio! immunoanalyzers are specially designed to exploit the benefits of Innotrac Diagnostics' exclusive dry chemistry and non-enhancement time-resolved fluorometry....
With an intuitive operator interface, enhanced sample handling and innovative menu, the state-of-the-art Access 2 system delivers new levels of laboratory efficiency, standardization and cost effecti...
...
...
Medicine Products: